US Stock MarketDetailed Quotes

PRME Prime Medicine

Watchlist

4.435
+0.135+3.14%

Trading Apr 26 15:44 ET

531.93MMarket Cap-2034P/E (TTM)

Prime Medicine Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

(Q1)Mar 31, 2022

Total revenue

Operating revenue

--0

Cost of revenue

Gross profit

Operating expense

64.14%191.29M

40.99%54.54M

62.56%51.46M

72.05%45.26M

101.19%40.03M

37.96%116.54M

-35.60%38.69M

203.59%31.66M

26.31M

19.9M

Selling and administrative expenses

45.50%43.39M

35.94%13.08M

58.78%10.49M

44.71%10.66M

47.13%9.15M

114.16%29.82M

33.92%9.63M

118.30%6.61M

--7.37M

--6.22M

-General and administrative expense

45.50%43.39M

35.94%13.08M

58.78%10.49M

44.71%10.66M

47.13%9.15M

114.16%29.82M

33.92%9.63M

118.30%6.61M

--7.37M

--6.22M

Research and development costs

70.54%147.91M

42.66%41.46M

63.56%40.97M

82.68%34.6M

125.78%30.88M

22.93%86.73M

-45.05%29.06M

238.47%25.05M

--18.94M

--13.68M

Operating profit

-64.14%-191.29M

-40.99%-54.54M

-62.56%-51.46M

-72.05%-45.26M

-101.19%-40.03M

-37.96%-116.54M

35.60%-38.69M

-203.59%-31.66M

-26.31M

-19.9M

Net non-operating interest income expense

Other net income (expense)

-14.38%-7.12M

-1,317.62%-11.1M

-74.45%643K

183.30%2.9M

109.70%434K

92.35%-6.23M

46.15%-783K

130.13%2.52M

-3.49M

-4.47M

Gain on sale of security

70.69%-2.38M

137.16%635K

-188.26%-1.58M

107.06%263K

62.07%-1.7M

-1,978.77%-8.13M

-16.58%-1.71M

121.41%1.79M

---3.72M

---4.49M

Special income (charges)

---13.5M

----

--0

----

-Less:Other special charges

--13.5M

----

Other non- operating income (expenses)

360.43%8.76M

90.60%1.77M

205.22%2.22M

1,009.24%2.64M

19,309.09%2.14M

102.35%1.9M

7,616.67%926K

72,900.00%728K

--238K

--11K

Income before tax

-61.61%-198.41M

-66.32%-65.64M

-74.40%-50.82M

-42.18%-42.35M

-62.48%-39.6M

25.98%-122.77M

35.85%-39.47M

-55.14%-29.14M

-29.79M

-24.37M

Income tax

70.57%-279K

-150.94%-108K

107.01%31K

62.03%-202K

-95.06%-948K

-113.47%-186K

108.95%212K

-442K

-532K

Net income

-62.64%-198.13M

-67.10%-65.64M

-72.77%-50.71M

-44.42%-42.39M

-65.26%-39.4M

26.33%-121.82M

37.56%-39.28M

-78.83%-29.35M

-29.35M

-23.84M

Net income continuous Operations

-62.64%-198.13M

-67.10%-65.64M

-72.77%-50.71M

-44.42%-42.39M

-65.26%-39.4M

26.33%-121.82M

37.56%-39.28M

-78.83%-29.35M

---29.35M

---23.84M

Minority interest income

Net income attributable to the parent company

-62.64%-198.13M

-67.10%-65.64M

-72.77%-50.71M

-44.42%-42.39M

-65.26%-39.4M

26.33%-121.82M

37.56%-39.28M

-78.83%-29.35M

-29.35M

-23.84M

Preferred stock dividends

16.83%20.19M

-79.35%1.31M

-0.02%6.36M

6.29M

6.22M

Other preferred stock dividends

Net income attributable to common stockholders

-39.52%-198.13M

-61.69%-65.64M

-41.99%-50.71M

-18.92%-42.39M

-31.04%-39.4M

22.87%-142.01M

41.40%-40.6M

-56.80%-35.71M

-35.64M

-30.06M

Basic earnings per share

47.97%-2.18

-28.57%-0.72

-45.29%-0.55

5.32%-0.47

-5.08%-0.44

-63.39%-4.19

41.96%-0.56

-19.34%-0.3786

-0.4964

-0.4187

Diluted earnings per share

47.97%-2.18

-28.57%-0.72

-45.29%-0.55

5.32%-0.47

-5.08%-0.44

-63.39%-4.19

41.96%-0.56

-19.34%-0.3786

-0.4964

-0.4187

Dividend per share

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

Unqualified Opinion with Explanatory Notes

	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022	(Q1)Mar 31, 2022
Total revenue	0	0	0	0	0	0	0	0	0	0
Operating revenue	--0	--0	--0	--0	--0	--0	--0	--0	--0	--0
Cost of revenue
Gross profit
Operating expense	64.14%191.29M	40.99%54.54M	62.56%51.46M	72.05%45.26M	101.19%40.03M	37.96%116.54M	-35.60%38.69M	203.59%31.66M	26.31M	19.9M
Selling and administrative expenses	45.50%43.39M	35.94%13.08M	58.78%10.49M	44.71%10.66M	47.13%9.15M	114.16%29.82M	33.92%9.63M	118.30%6.61M	--7.37M	--6.22M
-General and administrative expense	45.50%43.39M	35.94%13.08M	58.78%10.49M	44.71%10.66M	47.13%9.15M	114.16%29.82M	33.92%9.63M	118.30%6.61M	--7.37M	--6.22M
Research and development costs	70.54%147.91M	42.66%41.46M	63.56%40.97M	82.68%34.6M	125.78%30.88M	22.93%86.73M	-45.05%29.06M	238.47%25.05M	--18.94M	--13.68M
Operating profit	-64.14%-191.29M	-40.99%-54.54M	-62.56%-51.46M	-72.05%-45.26M	-101.19%-40.03M	-37.96%-116.54M	35.60%-38.69M	-203.59%-31.66M	-26.31M	-19.9M
Net non-operating interest income expense
Other net income (expense)	-14.38%-7.12M	-1,317.62%-11.1M	-74.45%643K	183.30%2.9M	109.70%434K	92.35%-6.23M	46.15%-783K	130.13%2.52M	-3.49M	-4.47M
Gain on sale of security	70.69%-2.38M	137.16%635K	-188.26%-1.58M	107.06%263K	62.07%-1.7M	-1,978.77%-8.13M	-16.58%-1.71M	121.41%1.79M	---3.72M	---4.49M
Special income (charges)	---13.5M	----	----	----	----	--0	----	----	----	----
-Less:Other special charges	--13.5M	----	----	----	----	----	----	----	----	----
Other non- operating income (expenses)	360.43%8.76M	90.60%1.77M	205.22%2.22M	1,009.24%2.64M	19,309.09%2.14M	102.35%1.9M	7,616.67%926K	72,900.00%728K	--238K	--11K
Income before tax	-61.61%-198.41M	-66.32%-65.64M	-74.40%-50.82M	-42.18%-42.35M	-62.48%-39.6M	25.98%-122.77M	35.85%-39.47M	-55.14%-29.14M	-29.79M	-24.37M
Income tax	70.57%-279K	0	-150.94%-108K	107.01%31K	62.03%-202K	-95.06%-948K	-113.47%-186K	108.95%212K	-442K	-532K
Net income	-62.64%-198.13M	-67.10%-65.64M	-72.77%-50.71M	-44.42%-42.39M	-65.26%-39.4M	26.33%-121.82M	37.56%-39.28M	-78.83%-29.35M	-29.35M	-23.84M
Net income continuous Operations	-62.64%-198.13M	-67.10%-65.64M	-72.77%-50.71M	-44.42%-42.39M	-65.26%-39.4M	26.33%-121.82M	37.56%-39.28M	-78.83%-29.35M	---29.35M	---23.84M
Minority interest income
Net income attributable to the parent company	-62.64%-198.13M	-67.10%-65.64M	-72.77%-50.71M	-44.42%-42.39M	-65.26%-39.4M	26.33%-121.82M	37.56%-39.28M	-78.83%-29.35M	-29.35M	-23.84M
Preferred stock dividends						16.83%20.19M	-79.35%1.31M	-0.02%6.36M	6.29M	6.22M
Other preferred stock dividends
Net income attributable to common stockholders	-39.52%-198.13M	-61.69%-65.64M	-41.99%-50.71M	-18.92%-42.39M	-31.04%-39.4M	22.87%-142.01M	41.40%-40.6M	-56.80%-35.71M	-35.64M	-30.06M
Basic earnings per share	47.97%-2.18	-28.57%-0.72	-45.29%-0.55	5.32%-0.47	-5.08%-0.44	-63.39%-4.19	41.96%-0.56	-19.34%-0.3786	-0.4964	-0.4187
Diluted earnings per share	47.97%-2.18	-28.57%-0.72	-45.29%-0.55	5.32%-0.47	-5.08%-0.44	-63.39%-4.19	41.96%-0.56	-19.34%-0.3786	-0.4964	-0.4187
Dividend per share
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	Unqualified Opinion	--	--	--	--	Unqualified Opinion with Explanatory Notes	--	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall